We are live on ! Find out more
AVIR icon

Atea Pharmaceuticals
AVIR

143 hedge funds and large institutions have $477M invested in Atea Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 47 increasing their positions, 35 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 35

11% more call options, than puts

Call options by funds: $15.8M | Put options by funds: $14.2M

2% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 47

1% more funds holding

Funds holding: 142 → 143 (+1)

4.15% less ownership

Funds ownership: 68.67% → 64.52% (-4.2%)

76% less capital invested

Capital invested by funds: $1.99B → $477M (-$1.52B)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
143
Holders Change
+1
Holders Change %
+0.7%
% of All Funds
2.2%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
48
Increased
47
Reduced
35
Closed
47
Calls
$15.8M
Puts
$14.2M
Net Calls
+$1.56M
Net Calls Change
+$326K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$83.8M
2
BlackRock
BlackRock
New York
+$25.6M
3
Citadel Advisors
Citadel Advisors
Florida
+$24.5M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$23.8M
5
State Street
State Street
Massachusetts
+$19.1M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$190M
2
PA
Perceptive Advisors
New York
-$79.2M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$58M
4
AIIC
AJU IB Investment Company
South Korea
-$57.4M
5
CAM
Cormorant Asset Management
Massachusetts
-$50.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
GTC
151
Ghost Tree Capital
New York
– -$5.26M -150,000 Closed
Canada Pension Plan Investment Board
152
Canada Pension Plan Investment Board
Ontario, Canada
– -$4.84M -138,000 Closed
EMFAT
153
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$4.34M -123,877 Closed
SCM
154
Soleus Capital Management
Connecticut
– -$4.12M -117,600 Closed
Millennium Management
155
Millennium Management
New York
– -$4.05M -115,671 Closed
PAMS
156
Pictet Asset Management (Switzerland)
Switzerland
– -$3.76M -107,306 Closed
SSA
157
Schonfeld Strategic Advisors
New York
– -$3.66M -104,378 Closed
MIM
158
Monashee Investment Management
Massachusetts
– -$3.51M -100,000 Closed
SAMH
159
Shanda Asset Management Holdings
British Virgin Islands
– -$3.51M -100,000 Closed
MCM
160
Moore Capital Management
New York
– -$3.11M -88,700 Closed
UOC
161
UBS O'Connor
Illinois
– -$1.75M -50,000 Closed
SEC
162
Seven Eight Capital
New York
– -$1.55M -44,320 Closed
JF
163
Jump Financial
Illinois
– -$1.51M -43,100 Closed
HM
164
HealthCor Management
New York
– -$1.28M -36,580 Closed
Bank of Montreal
165
Bank of Montreal
Ontario, Canada
– -$1.17M -36,106 Closed
IHAM
166
Integral Health Asset Management
New York
– -$1.05M -30,000 Closed
VF
167
Virtu Financial
New York
– -$930K -26,522 Closed
Ameriprise
168
Ameriprise
Minnesota
– -$885K -25,266 Closed
WJWM
169
Williams Jones Wealth Management
New York
– -$864K -24,645 Closed
HIIFS
170
Harel Insurance Investments & Financial Services
Israel
– -$701K -20,000 Closed
VCWA
171
Vanguard Capital Wealth Advisors
Colorado
– -$422 -12,050 Closed
Vontobel Holding
172
Vontobel Holding
Switzerland
– -$388K -11,076 Closed
AIM
173
Axiom Investment Management
New York
– -$336K -9,500 Closed
AB
174
Amalgamated Bank
New York
– -$308K -8,773 Closed
MCM
175
Mengis Capital Management
Oregon
– -$294K -8,400 Closed
4 5 6
7
8

AVIR Hedge Fund Activity: Q4 2021 in Review

143 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Atea Pharmaceuticals (AVIR) for Q4 2021, worth a combined $477M — down 76% from $1.99B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new AVIR positions and 47 closed out — a net gain of 1 holder — while 47 added to existing stakes and 35 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $83.8M. The largest seller was RA Capital Management, exiting entirely with an estimated $190M sold.

  • 143 institutional investors held Atea Pharmaceuticals (AVIR) as of Q4 2021, up from 142 in Q3 2021.
  • Funds reported $477M of Atea Pharmaceuticals stock for Q4 2021, down 76% quarter-over-quarter.
  • 48 funds opened new Atea Pharmaceuticals positions in Q4 2021 and 47 closed out, a net change of +1 holder.
  • The largest Atea Pharmaceuticals buyer in Q4 2021 was EcoR1 Capital, an estimated $83.8M added.
  • The largest Atea Pharmaceuticals seller in Q4 2021 was RA Capital Management, an estimated $190M sold.

Based on aggregated 13F filings for Q4 2021.